The detection and unambiguous identification
of anabolic-androgenic
steroid metabolites are essential in clinical, forensic, and antidoping
analyses. Recently, sulfate phase II steroid metabolites have received
increased attention in steroid metabolism and drug testing. In large
part, this is because phase II steroid metabolites are excreted for
an extended time, making them a potential long-term chemical marker
of choice for tracking steroid misuse in sports. Comprehensive analytical
methods, such as liquid chromatography–tandem mass spectrometry
(LC–MS/MS), have been used to detect and identify glucuronide
and sulfate steroids in human urine with high sensitivity and reliability.
However, LC–MS/MS identification strategies can be hindered
by the fact that phase II steroid metabolites generate nonselective
ion fragments across the different metabolite markers, limiting the
confidence in metabolite identifications that rely on exact mass measurement
and MS/MS information. Additionally, liquid chromatography–high-resolution
mass spectrometry (LC–HRMS) is sometimes insufficient at fully
resolving the analyte peaks from the sample matrix (commonly urine)
chemical noise, further complicating accurate identification efforts.
Therefore, we developed a liquid chromatography–ion mobility–high
resolution mass spectrometry (LC–IM–HRMS) method to
increase the peak capacity and utilize the IM-derived collision cross
section (CCS) values as an additional molecular descriptor for increased
selectivity and to improve identifications of intact steroid analyses
at low concentrations.